New study aims to map bipolar Disorder's path using blood and brain scans

NCT ID NCT07343739

Ongoing Knowledge-focused Sponsor: ASST Fatebenefratelli Sacco Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This observational study is tracking 126 people with bipolar disorder over 18 months to better understand how the condition progresses. Researchers will collect clinical data, blood and saliva samples, and brain scans at several time points. The goal is to combine all this information to create a more accurate staging model for bipolar disorder, which could eventually help tailor treatments to each person's stage of illness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could lead to a more precise way to track bipolar disorder progression and guide personalized treatments.
What could go wrong: This is an observational study, not a treatment trial. It may not directly lead to new therapies, and the findings may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bipolar disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIPOLAR DISORDER

Contacts and locations

Locations

ASST Fatebenefratelli Sacco

Milan, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.